Clinical evaluation
97%
Reported agreement with HAM-D
Reported across 500+ hospital assessments at Dr. Ram Manohar Lohia (RML) Hospital. Agreement is a validation metric; it is not a claim of diagnostic accuracy.
Sequoia Insilico Pvt. Ltd. · BioAI for brain & mental health
Connected intelligence for brain and mental healthcare.
SIPL connects clinical care, behavioural signals, neuroscience, genomics, and discovery through responsible AI infrastructure.
SIPL · Research framework
A connected view of biology
ClinicalGenomicMolecularPhenotypic
BioAI
Intelligence
Intelligence
EvidenceInsightsStratificationOutcomes
Research-led · Multimodal · Human-supervised · Evidence-linked
Granted
Indian patent
97%
HAM-D agreement
500+
hospital assessments
BIRAC
grant-backed validation
Evidence & milestones
Early proof, clearly framed.
Intellectual property
Indian patent
PCT filing reported
Patent No. 202511025669, with an active WIPO PCT filing, as reported by SIPL.
Research support
BIRAC GCE-III
Grant-backed development
Non-dilutive support for product development and validation, as reported by SIPL.
These milestones describe reported validation, IP, and grant support. They do not imply regulatory clearance, clinical utility beyond the reported evaluation, or commercial adoption. Supporting details can be requested from SIPL.
BioAI for biopharma
Connect patient biology, clinical outcomes, and discovery.
We build research infrastructure for complex brain and mental health questions. Multimodal data and computational methods help partners explore biomarkers, stratify populations, and understand response across development and real-world settings.
Discuss a research objective01
Multimodal biomarkers
Bring behavioural, clinical, and biological signals into a clearer research context.
02
Clinical development
Support study design, patient characterisation, and meaningful outcome measurement.
03
Genomics & discovery
Connect genomic findings with longitudinal clinical context to investigate biology and response.
Investor & strategic partners
A specialised BioAI platform connecting care and discovery.
SIPL is building at the convergence of brain health, multimodal biomarkers, genomics, clinical workflows, and biopharma research.
Start an investor conversationA focused starting point
Brain and mental health is a high-complexity domain where clinical context and biological variation matter.
A multimodal foundation
SIPL brings behavioural, clinical, and genomic research into a shared evidence framework.
A bridge from care to discovery
The long-term opportunity is to connect real-world clinical context with better research questions and evidence.
Who we work with
One scientific foundation. Different partner questions.
We work with teams close to the science and the people it serves. Partnerships begin with a clearly defined question, intended use, and evidence pathway.
Hospitals & health systems
Explore connected clinical workflows, longitudinal outcomes, and evidence generation.
Researchers & clinicians
Shape clinically relevant questions and evaluate multimodal signals responsibly.
Biopharma teams
Investigate patient stratification, clinical development, and real-world evidence.
Genomics partners
Connect genomic findings to phenotypes, clinical context, and outcomes over time.
Our approach
Scientific depth, responsible AI, practical collaboration.
Every research question starts with clinical relevance, clear data governance, and transparent evaluation. Qualified professionals remain responsible for interpretation and care.
Meet the team01
Purpose & consent
Use information with clear purpose and appropriate permissions.
02
Privacy & governance
Protect sensitive data with defined access and accountable processes.
03
Evidence & validation
Evaluate performance, uncertainty, and limitations with scientific discipline.
04
Human oversight
Keep qualified professionals accountable for interpretation and care.
Coming soon
Advisory Board
We are bringing together experienced voices across clinical care, neuroscience, genomics, research, and biopharma. More to come.
Partner with SIPL
Let’s build better evidence together.
For biopharma, clinical, research, and genomics collaborations, tell us what you are working on.
Start a conversation
Share a few details and our team will follow up.